Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Golabi, Pegah; Stepanova, Maria; Pham, Huong T; Cable, Rebecca; Rafiq, Nila; Bush, Haley; Gogoll, Trevor; Younossi, Zobair M

Golabi, Pegah; Stepanova, Maria; Pham, Huong T; Cable, Rebecca; Rafiq, Nila; Bush, Haley; Gogoll, Trevor; Younossi, Zobair M.

Afiliação

Golabi P; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Stepanova M; Center for Outcomes Research in Liver Disease, Columbia, Washington, USA.
Pham HT; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Cable R; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Rafiq N; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Bush H; Department of Medicine, Center For Liver Disease, Inova Fairfax Hospital, Falls Church, Virginia, USA.
Gogoll T; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Younossi ZM; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.

BMJ Open Gastroenterol ; 5(1): e000198, 2018.

Article em En | MEDLINE | ID: mdl-29607054

Palavras-chave

fatty liver; fibrosis; hepatic fibrosis; liver biopsy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: BMJ Open Gastroenterol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google